DEP-21521-03932
5 vaccinations
5 coded responses
43 check-ins
5 free-text entries
5 call cases
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 770 / TX
- Registered
- 2021-02-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-06
Dose 1 — Moderna
-
2021-02-04
Registered in v-safe
-
2021-02-04
Dose 2 — Moderna
- 2021-02-04
-
2021-02-05
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-06
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-02-07
Survey response — days 1–6 daily, dose 2MedDRA: Condition aggravated, Medical counselling, Pre-existing disease, Rash — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Systemic reaction (other): I had a rash before receiving first dose. It got worse 2-3 weeks after receiving first dose. It started to get worse again starting 2 days after receiving the second dose. · Healthcare visit (other): I have been under doctors care for rash since 2 weeks after receiving first dose. Since rash was present before first dose the vaccine probably didnt cause it but the vaccine may have exacerbated it.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-07
Report sent to call center — days 1–6 daily, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-08
Survey response — days 1–6 daily, dose 2MedDRA: Medical counselling, Rash — Feeling: Good · Rash, not including the immediate area around the injection site · Get care from a doctor or other healthcare professionalFree text: Systemic reaction (other): Rash is being treated with both topical and oral steroids. Some of the rash is improving but new areas of rash continue to appear. · Healthcare visit (other): Ongoing treatment with corticosteroidsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-08
Report sent to call center — days 1–6 daily, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-09
Survey response — days 1–6 daily, dose 2MedDRA: Rash — Feeling: Good · Rash, not including the immediate area around the injection site · Get care from a doctor or other healthcare professionalFree text: Im continuing to use an oral and a topical steroid that was prescribed by my doctor for the rash. The rash is clearing in most areas but expanding in others.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-09
Report sent to call center — days 1–6 daily, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-10
Survey response — days 1–6 daily, dose 2MedDRA: Rash — Feeling: Good · Rash, not including the immediate area around the injection site · Get care from a doctor or other healthcare professionalFree text: I am continuing to use a topical and a oral steroids for the rash. The rash is improving.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-10
Report sent to call center — days 1–6 daily, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-11
Survey response — day 7, dose 2MedDRA: Adverse reaction, Rash, Unevaluable event — Feeling: Good · Rash, not including the immediate area around the injection site · Get care from a doctor or other healthcare professionalFree text: Systemic reaction (other): Rash continues to improve. Stopped using topical steroid. Continuing oral steroid. · Healthcare visit (other): See prior comments.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-11
Report sent to call center — day 7, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-02-18
- 2021-02-25
- 2021-03-04
- 2021-03-11
- 2021-03-19
- 2021-05-07
-
2021-07-19
Call successfulParticipant prefers to complete VAERS report online
- 2021-08-06
-
2021-10-01
Dose 3 — Moderna
- 2021-10-25
- 2021-10-29
- 2021-11-05
- 2021-11-12
- 2021-12-31
- 2022-04-01
-
2022-04-15
Dose 4 — Moderna
- 2022-04-15
-
2022-04-16
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Chills, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-04-17
- 2022-04-18
- 2022-04-19
- 2022-04-20
- 2022-04-21
- 2022-04-22
- 2022-04-29
- 2022-05-06
- 2022-05-13
- 2022-05-20
- 2022-05-28
- 2022-07-15
-
2022-09-29
Dose 5 — Moderna
- 2022-10-10
- 2022-10-13
- 2022-10-20
- 2022-10-27
- 2022-11-03
- 2022-11-10
- 2022-12-29
- 2023-03-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-06 | Moderna | |
| 2 | 2021-02-04 | Moderna | |
| 3 | 2021-10-01 | Moderna | No |
| 4 | 2022-04-15 | Moderna | No |
| 5 | 2022-09-29 | Moderna | No |
Call center
5 call center cases
5 successful
Free text
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): I had a rash before receiving first dose. It got worse 2-3 weeks after receiving first dose. It started to get worse again starting 2 days after receiving the second dose.
Healthcare visit (other): I have been under doctors care for rash since 2 weeks after receiving first dose. Since rash was present before first dose the vaccine probably didnt cause it but the vaccine may have exacerbated it.
Systemic reaction (other): Rash is being treated with both topical and oral steroids. Some of the rash is improving but new areas of rash continue to appear.
Healthcare visit (other): Ongoing treatment with corticosteroids
Healthcare visit (other): Im continuing to use an oral and a topical steroid that was prescribed by my doctor for the rash. The rash is clearing in most areas but expanding in others.
Release 4 — days 1–6 daily, dose 2
Healthcare visit (other): I am continuing to use a topical and a oral steroids for the rash. The rash is improving.
Release 4 — day 7, dose 2
Systemic reaction (other): Rash continues to improve. Stopped using topical steroid. Continuing oral steroid.
Healthcare visit (other): See prior comments.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Medical counselling | ✓ | ✓ | ✓ |
| HCVO | Rash | ✓ | ✓ | ✓ |
| HCVO | Unevaluable event | ✓ | ✓ | ✓ |
| SRO | Adverse reaction | ○ | ✓ | ○ |
| SRO | Condition aggravated | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Rash | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release